Cowen and Company’s Biote Corp BTMD Stock Holding History

Cowen and Company’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,970	Closed	-$49K	–	677
2022 Q2	$49K	Buy	+12,970	New	+$102K	﹤0.01%	309

Other funds holding BTMD

Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Cowen and Company's BTMD Position: Q3 2022 in Review

Cowen and Company sold out of Biote Corp (BTMD) in Q3 2022, closing a stake of 12,970 shares — an estimated $49K sold.

Cowen and Company first reported a position in BTMD in Q2 2022 and held it in 1 quarter. The position peaked at $49K in Q2 2022. 16 funds tracked by Wall St. Rank hold BTMD as of Q3 2022.

Cowen and Company reported no remaining Biote Corp position as of Q3 2022 after selling out during the quarter.
Cowen and Company sold 12,970 Biote Corp shares in Q3 2022, an estimated $49K.
Cowen and Company first reported a position in Biote Corp in Q2 2022 and held it in 1 quarter.
Cowen and Company's Biote Corp position peaked at $49K in Q2 2022.
16 funds tracked by Wall St. Rank held Biote Corp as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.